Table 3 Pregnancy outcomes
| Â | Extended letrozole group (n = 106) | Clomiphene citrate group (n = 105) | Odd ratio (95% CI) | P value |
|---|---|---|---|---|
No of completed cycles | 211 | 210 | Â | Â |
Clinical pregnancy/cycle | 40/211(18.96%) | 24/210(11.43%) | 1.81(1.05, 3.13) | 0.031 |
Cumulative pregnancy rate | 40/106(37.73%) | 24/105(22.86%) | 2.05(1.12, 3.73) | 0.019 |
Ongoing pregnancy rate | 35/106(33.02%) | 20/105(19.05%) | 2.09(1.11, 3.95) | 0.02 |
Abortion rate | 5/40(12.5%) | 4/24(16.67%) | 0.71(0.17, 2.97) | 0.926 |
Multiple pregnancy rate | 4/40(10%) | 3/24(12.5%) | 0.78(0.16, 3.82) | 0.756 |
Ectopic pregnancy rate | 0/40(0%) | 0/24(0%) | NA | NA |
OHSS | 0/106 (0%) | 0/105(0%) | NA | NA |